The Child with Recurrent Mycobacterial Disease

Area of Science:

• Immunology
• Genetics
• Infectious Diseases

Background:

• Genetic conditions predispose individuals to opportunistic infections.
• Mendelian susceptibility to mycobacterial disease (MSMD) is a group of genetic immunodeficiencies allowing infections by various mycobacteria.
• Defects in IL-12 and NFKB signaling pathways are implicated in MSMD.

Purpose of the Study:

• To review known genetic defects causing MSMD.
• To describe clinical findings associated with MSMD mutations.
• To outline diagnostic and therapeutic approaches for MSMD.

Main Methods:

• Review of reported autosomal recessive, dominant, and X-linked recessive gene defects in MSMD.
• Correlation of genetic mutations with clinical manifestations.
• Discussion of diagnostic strategies including clinical evaluation, screening tests, and genetic testing.
• Overview of treatment options based on disease severity.

Main Results:

• Multiple gene defects leading to MSMD have been identified, with more awaiting discovery.
• Clinical presentation varies depending on the specific genetic mutation.
• Genetic testing is crucial for definitive diagnosis and genetic counseling.
• Treatment strategies are tailored to disease severity, including antibiotics and hematopoietic stem cell transplantation.

Conclusions:

• MSMD encompasses a spectrum of genetic defects affecting immune responses to mycobacteria.
• Early and accurate diagnosis through genetic testing is essential for effective management.
• Treatment approaches are evolving, offering improved outcomes for patients with MSMD.